Omega-3s and Fish Oil: Sorting the Evidence from the Hype
Omega-3s (EPA and DHA) have real cardiovascular evidence and a weaker cognitive story. Here is what the trials show, plus the atrial-fibrillation caveat.
What omega-3s are
Omega-3 fatty acids - mainly EPA and DHA from fatty fish - are essential fats your body cannot make efficiently. They are among the best-studied supplements on the market.
Heart health: the strongest case
A 2025 systematic review and meta-analysis found omega-3s associated with significant reductions in cardiovascular disease, coronary disease, and cardiac death (meta-analysis). The nuance: EPA-heavy formulas showed clearer benefit than EPA+DHA combinations in some high-risk groups. One real caveat - high-dose supplements may modestly raise the risk of atrial fibrillation, so more is not automatically better.
Brain health: weaker than marketed
Despite the “brain food” reputation, omega-3 supplements have not reliably improved cognition in healthy older adults - a meta-analysis of 11 trials found no significant effect (cognition review). The evidence is a little more hopeful for people who already have cognitive impairment, but supplementation is not a proven prevention.
Food first
Eating fatty fish such as salmon, sardines, or mackerel twice a week is the most evidence-backed way to get omega-3s. Supplements make sense if you do not eat fish; choose a reputable, third-party-tested brand to avoid rancidity and contaminants.
Bottom line
Omega-3s earn their reputation for heart health, especially from food and in higher-risk people. The cognitive claims outrun the data, and very high doses carry an atrial-fibrillation trade-off. Aim for fish first, supplement sensibly, and skip mega-doses unless a doctor directs them.
This article is for general education and is not medical advice.
Sources: Omega-3s and cardiovascular disease risk: meta-analysis (Wiley, 2025) | Omega-3 fatty acids and cognitive function (PubMed)
